Thomas Catinazzo
Chief Financial Officer
SEC EDGAR ↗Chief Financial Officer at Relay Therapeutics, Inc., filing insider transactions between 2025-04-28 and 2026-06-22.
Total Purchases
—
0 transactions
Total Sales
$4.3M
18 transactions
Companies Traded
1
18 total filings
Active Since
2025-04-28
Last: 2026-06-22
Other Reporting Insiders at Relay Therapeutics, Inc.
Transaction History
| Date | Ticker | Type | Shares | Price | Value | Owned After | |
|---|
| 2026-06-22 | RLAY | Sale | 61.6K | $16.97 | $1.0M | 177.5K | SEC ↗ |
| 2026-06-22 | RLAY | Sale | 56.3K | $16.97 | $956K | 177.5K | SEC ↗ |
| 2026-06-22 | RLAY | Sale | 51.6K | $16.97 | $875K | 177.5K |
Director & President and CEO
| 2026-06-22 | RLAY | Sale | 17.7K | $17.01 | $301K | 177.5K | SEC ↗ |
| 2026-05-14 | RLAY | Sale | 17.7K | $12.86 | $228K | 195.2K | SEC ↗ |
| 2026-04-07 | RLAY | Sale | 17.7K | $13.01 | $230K | 213.9K | SEC ↗ |
| 2026-03-09 | RLAY | Sale | 17.7K | $10.06 | $178K | 231.6K | SEC ↗ |
Thomas Catinazzo (Relay Therapeutics, Inc.) Insider Trades | Tormere